Drugs

Gilead and Merck’s once-weekly HIV pill passes two major trials

HQ Team June 10, 2026: Pharmaceutical giants Gilead Sciences and Merck announced that a once-weekly, single-tablet HIV treatment made up of islatravir and.

Read More
Drugs Health Pharma

Gilead, Global Fund to supply HIV prevention drug to two million people

HQ Team July 10, 2025: Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at.

Read More
Pharma

Gilead’s once-yearly lenacapavir shot for HIV prevention shows strong promise

HQ Team March 12, 2025: In a significant development for HIV prevention, Gilead Sciences has unveiled promising data from its Phase 1 study.

Read More